v3.22.2.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Oct. 31, 2022
Oct. 31, 2021
Operating activities    
Net loss $ (133,353) $ (190,639)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation and amortization 53,622 39,506
Amortization of intangible assets 12,338 9,072
Amortization of deferred contract acquisition costs 121,550 79,712
Non-cash operating lease cost 6,818 6,727
Stock-based compensation expense 374,157 217,315
Deferred income taxes 2,286 (1,338)
Non-cash interest expense 2,077 1,824
Change in fair value of strategic investments (4,757) (4,356)
Changes in operating assets and liabilities, net of impact of acquisitions    
Accounts receivable, net (117,240) (40,644)
Deferred contract acquisition costs (183,265) (151,901)
Prepaid expenses and other assets (14,121) (8,051)
Accounts payable 25,007 (7,033)
Accrued expenses and other liabilities 21,820 74,426
Accrued payroll and benefits 21,635 22,258
Operating lease liabilities (7,037) (7,394)
Deferred revenue 486,177 375,582
Net cash provided by operating activities 667,714 415,066
Investing activities    
Purchases of property and equipment (179,609) (85,420)
Capitalized internal-use software and website development costs (20,739) (15,201)
Purchase of strategic investments (18,006) (15,809)
Business acquisitions, net of cash acquired (18,464) (353,746)
Purchase of intangible assets (700) (680)
Net cash used in investing activities (237,518) (470,856)
Financing activities    
Payment of debt issuance costs related to revolving line of credit 0 (219)
Payment of debt issuance costs related to Senior Notes 0 (1,581)
Repayment of loan payable (1,591) 0
Proceeds from issuance of common stock upon exercise of stock options 6,396 12,796
Proceeds from issuance of common stock under the employee stock purchase plan 34,445 27,452
Capital contributions from non-controlling interest holders 9,053 7,905
Net cash provided by financing activities 48,303 46,353
Effect of foreign exchange rates on cash, cash equivalents and restricted cash (7,074) (1,663)
Net increase (decrease) in cash, cash equivalents and restricted cash 471,425 (11,100)
Cash, cash equivalents and restricted cash at beginning of period 1,996,633 1,918,608
Cash, cash equivalents and restricted cash at end of period 2,468,058 1,907,508
Cash and cash equivalents 2,466,551 1,907,508
Restricted cash included in prepaid expenses and other assets 1,507 0
Total cash, cash equivalents and restricted cash shown in the condensed consolidated statements of cash flows 2,468,058 1,907,508
Supplemental disclosure of cash flow information:    
Interest paid 22,547 13,048
Income taxes paid, net of refunds received 6,769 3,854
Supplemental disclosure of non-cash investing and financing activities:    
Net increase in property and equipment included in accounts payable and accrued expenses 13,271 7,066
Vesting of early exercised stock options 2,204 2,389
Equity consideration for acquisitions 50 4,011
Operating lease liabilities arising from obtaining operating right of-use assets $ 1,702 $ 4,591